Texas Medical Advisor, Inc. – Trademark Portfolio
Entity Type: 03
Texas Medical Advisor, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TEXAS MEDICAL ADVISOR. The owner is based in Austin, TX.
Austin, TX 78701
Showing of trademarks Trademarks
Trademark Classifications
Texas Medical Advisor, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Texas Medical Advisor, Inc. have?
Texas Medical Advisor, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Texas Medical Advisor, Inc. file in?
Texas Medical Advisor, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Texas Medical Advisor, Inc.'s most well-known trademarks?
Texas Medical Advisor, Inc.'s registered trademark portfolio includes well-known marks such as TEXAS MEDICAL ADVISOR. These are among 1 currently registered trademark in the portfolio.
What is Texas Medical Advisor, Inc.'s trademark registration success rate?
Texas Medical Advisor, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.